These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30978341)

  • 1. Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma.
    He S; Li Z; Yu Y; Zeng Q; Cheng Y; Ji W; Xia W; Lu S
    Exp Cell Res; 2019 Jun; 379(2):203-213. PubMed ID: 30978341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling.
    Yu F; Liang M; Huang Y; Wu W; Zheng B; Chen C
    J Exp Clin Cancer Res; 2021 Jun; 40(1):179. PubMed ID: 34074322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
    Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
    Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
    Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
    Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-21-5p knockdown inhibits epithelial to mesenchymal transition in A549 lung adenocarcinoma cells by upregulating RhoB.
    Khair HHA; Karagöz ID
    Mol Biol Rep; 2024 Jul; 51(1):837. PubMed ID: 39042337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer.
    Hsu XR; Wu JE; Wu YY; Hsiao SY; Liang JL; Wu YJ; Tung CH; Huang MF; Lin MS; Yang PC; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2023 Oct; 42(1):283. PubMed ID: 37880793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2.
    Zhu D; Gu L; Li Z; Jin W; Lu Q; Ren T
    Pathol Res Pract; 2019 May; 215(5):861-872. PubMed ID: 30712885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition.
    Li Q; Li B; Li Q; Wei S; He Z; Huang X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
    Cell Death Dis; 2018 Aug; 9(9):854. PubMed ID: 30154401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
    Xiao G; Wang P; Zheng X; Liu D; Sun X
    Cell Cycle; 2019 Nov; 18(21):2972-2985. PubMed ID: 31522616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-mediated transfer of miR-1260b promotes cell invasion through Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Xia Y; Wei K; Hu LQ; Zhou CR; Lu ZB; Zhan GS; Pan XL; Pan CF; Wang J; Wen W; Xu J; He ZC; Huang CJ; Chen L
    J Cell Physiol; 2020 Oct; 235(10):6843-6853. PubMed ID: 32026462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal transfer of miR-195-5p restrains lung adenocarcinoma progression.
    Zhou Y; Wang G; Cai J; Du Y; Li H; Duan L; Zhao G; Huang Y
    Exp Cell Res; 2023 Mar; 424(1):113485. PubMed ID: 36657657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
    Xin H; Wang C; Liu Z
    BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent hypoxia BMSCs-derived exosomal miR-31-5p promotes lung adenocarcinoma development via WDR5-induced epithelial mesenchymal transition.
    Ren J
    Sleep Breath; 2023 Aug; 27(4):1399-1409. PubMed ID: 36409397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miR-1228-5p down-regulates DUSP22 to promotes cell proliferation and migration in small cell lung cancer.
    Mu X; Yu C; Zhao Y; Hu X; Wang H; He Y; Wu H
    Life Sci; 2024 Aug; 351():122787. PubMed ID: 38851418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H; Zhang Z; Qing X; French SW; Liu D
    Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-508-5p serves as an anti-oncogene by targeting S100A16 to regulate AKT signaling and epithelial-mesenchymal transition process in lung adenocarcinoma cells.
    Wu C; Yang J; Lin X; Li R; Wu J
    Am J Med Sci; 2023 Jun; 365(6):520-531. PubMed ID: 36967030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
    Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
    J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.